Trio contrast approaches taken by Britain versus the US concerning mitochondrial replacement therapy image

MedicalXpress, April 10, 2015
Bob Yirka, citing I. Glenn Cohen (Faculty Director) et al.

Links

Read the Full Article

Glenn Cohen, with Harvard University, Julian Savulescu, with the University of Oxford and Eli Adashi with Brown University have together written and published a Perspectives piece in the journal Science, describing the differing approaches being taken regarding mitochondrial replacement therapy (MRT) in the U.S. versus Britain, and offer their opinion on how things should change in the U.S. [...]

bioethics biotechnology fda genetics health law policy i. glenn cohen international regulation reproductive technologies